Gallery
- PM Modi visit USAOnly the mirror in my washroom and phone gallery see the crazy me : Sara KhanKarnataka rain fury: Photos of flooded streets, uprooted treesCannes 2022: Deepika Padukone stuns at the French Riviera in Sabyasachi outfitRanbir Kapoor And Alia Bhatt's Wedding Pics - Sealed With A KissOscars 2022: Every Academy Award WinnerShane Warne (1969-2022): Australian cricket legend's life in picturesPhotos: What Russia's invasion of Ukraine looks like on the groundLata Mangeshkar (1929-2022): A pictorial tribute to the 'Nightingale of India'PM Modi unveils 216-feet tall Statue of Equality in Hyderabad (PHOTOS)
The 15th Hockey India Senior Men National Championship, set to take place from April 4 to
- Mensik denies Djokovic 100th title in Miami final
- KIPG: Son of a vegetable vendor, Bihar’s Jhandu Kumar eyes Worlds, 2028 Paralympics
- Hardik Singh credits hard work and team unity for receiving HI Midfielder of the Year award
- Djokovic, Alcaraz land in same half of Miami draw
- India to host 2nd Asian Yogasana Championships from March 29 to 31
No way to distinguish Omicron cases from Delta, US doctors in a fix Last Updated : 04 Jan 2022 07:57:53 AM IST Amid rising concerns over a fresh surge in coronavirus disease (Covid-19) cases, doctors in the United States are faced with a peculiar conundrum – they have no ready way of determining which variant of the coronavirus a person is carrying. This is especially troublesome because a high-risk patient infected with the Delta variant would greatly benefit from two particular monoclonal antibody treatments, while they would do little to nothing for a patient infected with the new, highly transmissible Omicron variant – which requires a third antibody treatment.
While U.S. officials have endorsed using a workaround test that can identify Omicron’s genetic signature, experts say it’s not feasible for large health systems facing a crush of patients to employ in each case.That makes treating patients challenging in places like Maryland, where cases are spiking and Omicron accounts for roughly 58 percent of them. The Delta variant is also holding strong in the Great Plains and swaths of the West, including California.While there is no approved test to determine each individual’s variant, a national network of state and other labs use genome-sequencing tests to track variants broadly in communities. Health systems then use those regional estimates or their own data to decide which antibody treatments to use in their clinics and hospitals.IANS Washington For Latest Updates Please-
Join us on
Follow us on
172.31.16.186